Vaccinia virus inhibits T cell receptor-dependent responses by human gammadelta T cells.
Vaccinia virus (VV) is an effective vaccine and vector but has evolved multiple mechanisms for evading host immunity. We characterized the interactions of VV (TianTan and New York City Board of Health strains) with human gammadelta T cells because of the role they play in immune control of this virus. Exposure to VV failed to trigger proliferative responses in gammadelta T cells from unprimed individuals, but it was an unexpected finding that VV blocked responses to model antigens by the Vgamma2Vdelta2 T cell subset. Infectious or ultraviolet light-inactivated VV inhibited proliferative Vgamma2Vdelta2 T cell responses to phosphoantigens and tumor cells, prevented cytolysis of Daudi B cells, and reduced cytokine production. Inhibiting Vgamma2Vdelta2 T cells may be a mechanism for evading host immunity and increasing VV virulence. Increased VV replication or expression in the absence of gammadelta T cell responses might contribute to its potency as a vaccine against poxvirus and recombinant antigens.
Li
Haishan
H
Institute of Human Virology, University of Maryland, Baltimore, MD 21201, USA.
Deetz
Carl O
CO
Zapata
Juan Carlos
JC
Cairo
Cristiana
C
Hebbeler
Andrew M
AM
Propp
Nadia
N
Salvato
Maria S
MS
Shao
Yiming
Y
Pauza
C David
CD
D006801:Humans; D007963:Leukocytes, Mononuclear; D016692:Receptors, Antigen, T-Cell, gamma-delta / Q000096:biosynthesis / Q000235:genetics / Q000502:physiology*; D011971:Receptors, Immunologic / Q000235:genetics; D016176:T-Lymphocyte Subsets / Q000276:immunology* / Q000821:virology; D013602:T-Lymphocytes, Cytotoxic / Q000187:drug effects / Q000276:immunology*; D014615:Vaccinia / Q000235:genetics / Q000276:immunology / Q000821:virology; D014616:Vaccinia virus / Q000276:immunology* / Q000472:pathogenicity
D016692:Receptors, Antigen, T-Cell, gamma-delta; D011971:Receptors, Immunologic